pharma news today glp-1 obesity Prime Therapeutics' leading research shows only 1 in 12 remain on a drug for at three years Obesity GLP-1 Market Size to

GHK-Cu is generally well tolerated, with fewer reports of scalp irritation

Protein stabilizes blood sugar and protects lean mass during weight loss (American Society for Nutrition position paper, 2020)

Many patients choose lipotropic B12 shots because they blend nutrient support with fat-mobilizing compounds

Structural insights into beta-1,3-glucan cleavage by a glycoside hydrolase family

Beyond weight loss, the SELECT trial showed semaglutide reduces major adverse cardiovascular events by 20 percent in patients with obesity and established cardiovascular disease, even without diabetes [Lincoff SELECT, NEJM 2023]